Johnson & Johnson paid its 5 named executives $82.7M in total in FY2025 (Dec). CEO J. Duato was paid $32.8M of that.
PayNo stock prices for these years
Pay of each named executive
J. DuatoChairman/CEO
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) | ||||||
| FY2022 (Dec) | ||||||
| FY2021 (Dec) | ||||||
| FY2020 (Dec) |
6 years
J. WolkEVP, CFO
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) | ||||||
| FY2022 (Dec) | ||||||
| FY2021 (Dec) | ||||||
| FY2020 (Dec) |
6 years
J. TaubertEVP, Worldwide Chair Pharmaceuticals
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) | ||||||
| FY2022 (Dec) | ||||||
| FY2021 (Dec) | ||||||
| FY2020 (Dec) |
6 years
Joaquin DuatoChair of the Board
| FY2021 (Dec) | ||||||
| FY2020 (Dec) | ||||||
| FY2019 (Dec) | ||||||
| FY2018 (Dec) | ||||||
| FY2017 (Dec) | ||||||
| FY2016 (Dec) |
6 years
J. ReedEVP, Innovative Medicine, R&D
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) |
3 years
T. SchmidEVP, WWC, MedTech
| FY2025 (Dec) | ||||||
| FY2024 (Dec) |
2 years
CEO pay against the pay peers
No CEO pay of the disclosed peers is on file for FY2023 (Dec).
- 1Johnson & JohnsonThis company
- 2Abbvie Inc.Not disclosed
- 3Merck & Co., Inc.Not disclosed
- 4Pfizer Inc.Not disclosed
Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.